💊 Sanofi goes big down under; PAHO launches an AI assistant for alcoholism

#231 | Uganda's Ebola crisis over? 🤞🏽

Hello, and welcome back to The Kable. If you read our longish read yesterday on the market for traditional medicine in Africa, write and let us know your thoughts. We live for feedback.

"Grab your HCP where they live" seems to be increasingly becoming the motto for pharma outreach. Novartis was first off the block with the launch of its Netflix-style service for rheumatologists called PEAK (Personalized Education and Knowledge). Then Indian drugmaker Mankind Pharma launched its video service for HCPs, called DocFlix, earlier this year. Now Evermed, the software company that powers Novartis' service, has tied up with healthcare marketing agency Havas Health & You for yet another video service, delivering content tailored for doctors.

French drugmaker Sanofi is pumping in $280 million into a third global vaccine hub, an mRNA-based hub in Queensland, Australia, to boost its mRNA expansion plans. The new hub will debut with the world's first mRNA-based chlamydia vaccine and jabs for flu and RSV.

In Uganda, the health ministry has spent the last couple of months dealing with an outbreak of Sudan Ebolavirus with no drugs or vaccines at hand. Now, experimental vaccines are finally making their way into the country for trials. However, there don't seem to be any infected patients left to test the vaccines on, with the health minister tweeting earlier this week that the last patient has been discharged.

And finally, Indonesia has been making a lot of policy and infrastructure moves lately to position itself as a global health hub. In a significant step forward into the 21st century, the country's parliament has now voted to outlaw extra-marital sex. Because only married people have healthy sex.